Advanced search
Publication Cover
Transcription Volume 10, 2019 - Issue 2: Transcriptional Cyclin-Dependent Kinases
Submit an article Journal homepage
8,175
Views
63
CrossRef citations to date
0
Altmetric
Review

Regulatory functions of the Mediator kinases CDK8 and CDK19

Charli B. FantDepartment of Biochemistry, University of Colorado, Boulder, CO, USAView further author information
&
Dylan J. TaatjesDepartment of Biochemistry, University of Colorado, Boulder, CO, USACorrespondence[email protected]
View further author information
Pages 76-90 | Received 19 Sep 2018, Accepted 20 Nov 2018, Published online: 26 Dec 2018

Citations (63)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Azlann Arnett, Keagan G. Moo, Kaitlin J. Flynn, Thomas B. Sundberg, Liv Johannessen, Alykhan F. Shamji, Nathanael S. Gray, Thomas Decker, Ye Zheng, Vivian H. Gersuk, Ziaur S. Rahman, David E. Levy, Isabelle J. Marié, Peter S. Linsley, Ramnik J. Xavier & Bernard Khor. (2021) The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway. Molecular and Cellular Biology 41:9.
Read now
Joaquin M. Espinosa. (2019) Transcriptional CDKs in the spotlight. Transcription 10:2, pages 45-46.
Read now

Articles from other publishers (61)

Mariah V. Salcedo, Nathan Gravel, Abbas Keshavarzi, Liang-Chin Huang, Krzysztof J. Kochut & Natarajan Kannan. (2023) Predicting protein and pathway associations for understudied dark kinases using pattern-constrained knowledge graph embedding. PeerJ 11, pages e15815.
Crossref
Mariko Okada, Mitsuaki Fujimoto, Pratibha Srivastava, Akanksha Pandey, Ryosuke Takii & Akira Nakai. (2023) The Mediator subunit MED12 promotes formation of HSF1 condensates on heat shock response element arrays in heat‐shocked cells . FEBS Letters 597:13, pages 1702-1717.
Crossref
Dong Dai, Jiang Yu, Ting Huang, Yansheng Li, Ziyang Wang, Shuangmeng Yang, Shuai Li, Yanli Li, Wenfeng Gou, Deguan Li, Wenbin Hou, Saijun Fan, Yiliang Li & Yu Zhao. (2023) PET imaging of new target CDK19 in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging.
Crossref
Micah G. Donovan, Matthew D. Galbraith & Joaquin M. Espinosa. (2022) Multi-omics investigation reveals functional specialization of transcriptional cyclin dependent kinases in cancer biology. Scientific Reports 12:1.
Crossref
Farazul Haque, Tasuku Honjo & Nasim A. Begum. (2022) XLID syndrome gene Med12 promotes Ig isotype switching through chromatin modification and enhancer RNA regulation. Science Advances 8:47.
Crossref
Leonid A. Ilchuk, Nina I. Stavskaya, Ekaterina A. Varlamova, Alvina I. Khamidullina, Victor V. Tatarskiy, Vladislav A. Mogila, Ksenia B. Kolbutova, Sergey A. Bogdan, Alexey M. Sheremetov, Alexandr N. Baulin, Irina A. Filatova, Yulia Yu. Silaeva, Maxim A. Filatov & Alexandra V. Bruter. (2022) Limitations of Tamoxifen Application for In Vivo Genome Editing Using Cre/ERT2 System. International Journal of Molecular Sciences 23:22, pages 14077.
Crossref
Jen-Chieh Lee, Shu Liu, Yucheng Wang, You Liang & David M. Jablons. (2022) MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway. Oncotarget 13:1, pages 1217-1236.
Crossref
Marius V. Dannappel, Danxi Zhu, Xin Sun, Hui Kheng Chua, Marle Poppelaars, Monica Suehiro, Subash Khadka, Terry C.C. Lim Kam Sian, Dhanya Sooraj, Melissa Loi, Hugh Gao, Daniel Croagh, Roger J. Daly, Pouya Faridi, Thomas G. Boyer & Ron Firestein. (2022) CDK8 and CDK19 regulate intestinal differentiation and homeostasis via the chromatin remodeling complex SWI/SNF. Journal of Clinical Investigation 132:20.
Crossref
Emilia Dimitrova, Angelika Feldmann, Robin H. van der Weide, Koen D. Flach, Anna Lastuvkova, Elzo de Wit & Robert J. Klose. (2022) Distinct roles for CKM–Mediator in controlling Polycomb-dependent chromosomal interactions and priming genes for induction. Nature Structural & Molecular Biology 29:10, pages 1000-1010.
Crossref
Vera E. van der Noord, Bob van de Water & Sylvia E. Le Dévédec. (2022) Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery. Cancers 14:18, pages 4353.
Crossref
Xiaokai Ding, Amanda C. Sharko, Martina S. J. McDermott, Gary P. Schools, Alexander Chumanevich, Hao Ji, Jing Li, Li Zhang, Zachary T. Mack, Vitali Sikirzhytski, Michael Shtutman, Laura Ivers, Norma O’Donovan, John Crown, Balázs Győrffy, Mengqian Chen, Igor B. Roninson & Eugenia V. Broude. (2022) Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo. Proceedings of the National Academy of Sciences 119:32.
Crossref
Qiwei Yang, Michal Ciebiera, Maria Victoria Bariani, Mohamed Ali, Hoda Elkafas, Thomas G Boyer & Ayman Al-Hendy. (2022) Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocrine Reviews 43:4, pages 678-719.
Crossref
Zhenfeng Shi, Lei Tian, Taotao Qiang, Jingyi Li, Yue Xing, Xiaodong Ren, Chang Liu & Chengyuan Liang. (2022) From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy. Journal of Medicinal Chemistry 65:9, pages 6390-6418.
Crossref
Anne Offermann, Vincent Joerg, Finn Becker, Marie C. Roesch, Duan Kang, Anna-Lena Lemster, Lars Tharun, Jochen Behrends, Axel S. Merseburger, Zoran Culig, Verena Sailer, Johannes Brägelmann, Jutta Kirfel & Sven Perner. (2022) Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer. The American Journal of Pathology 192:5, pages 813-823.
Crossref
Joel Rovnak & Sandra L. Quackenbush. (2022) Exploitation of the Mediator complex by viruses. PLOS Pathogens 18:4, pages e1010422.
Crossref
Sribalasubashini Muralimanoharan, Ross Shamby, Nicholas Stansbury, Robert Schenken, Barbara de la Pena Avalos, Samin Javanmardi, Eloise Dray, Patrick Sung & Thomas G. Boyer. (2022) Aberrant R-loop-induced replication stress in MED12-mutant uterine fibroids. Scientific Reports 12:1.
Crossref
Sonia Dębek & Przemysław Juszczyński. (2022) Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:2, pages 188697.
Crossref
Judith H. I. Haarhuis, Robin H. van der Weide, Vincent A. Blomen, Koen D. Flach, Hans Teunissen, Laureen Willems, Thijn R. Brummelkamp, Benjamin D. Rowland & Elzo de Wit. (2022) A Mediator-cohesin axis controls heterochromatin domain formation. Nature Communications 13:1.
Crossref
Yi Liu, Leilei Fu, Junhao Wu, Ming Liu, Guan Wang, Bo Liu & Lan Zhang. (2022) Transcriptional cyclin-dependent kinases: Potential drug targets in cancer therapy. European Journal of Medicinal Chemistry 229, pages 114056.
Crossref
Srishti Srivastava, Hima Makala, Vikas Sharma, Vaishali Suri, Chitra Sarkar & Ritu Kulshreshtha. (2022) MED12 is overexpressed in glioblastoma patients and serves as an oncogene by targeting the VDR/BCL6/p53 axis. Cellular and Molecular Life Sciences 79:2.
Crossref
Stephin J. Vervoort, Jennifer R. Devlin, Nicholas Kwiatkowski, Mingxing Teng, Nathanael S. Gray & Ricky W. Johnstone. (2021) Targeting transcription cycles in cancer. Nature Reviews Cancer 22:1, pages 5-24.
Crossref
Dhanya Sooraj, Claire Sun, Anh Doan, Daniel J. Garama, Marius V. Dannappel, Danxi Zhu, Hui K. Chua, Sylvia Mahara, Wan Amir Wan Hassan, Yeng Kwang Tay, Aleks Guanizo, Daniel Croagh, Zdenka Prodanovic, Daniel J. Gough, Chunhua Wan & Ron Firestein. (2022) MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase. Molecular Cell 82:1, pages 123-139.e7.
Crossref
Lindsey M Jackson, Ashna Dhoonmoon, Anastasia Hale, Kady A Dennis, Emily M Schleicher, Claudia M Nicolae & George-Lucian Moldovan. (2021) Loss of MED12 activates the TGFβ pathway to promote chemoresistance and replication fork stability in BRCA-deficient cells. Nucleic Acids Research 49:22, pages 12855-12869.
Crossref
Lindsey Barron, Subash Khadka, Robert Schenken, Long He, John Blenis, Julian Blagg, Shin-Fu Chen, Kuang-Lei Tsai & Thomas G. Boyer. (2021) Identification and characterization of the mediator kinase-dependent myometrial stem cell phosphoproteome. F&S Science 2:4, pages 383-395.
Crossref
Brittany Friedson & Katrina F. Cooper. (2021) Cdk8 Kinase Module: A Mediator of Life and Death Decisions in Times of Stress. Microorganisms 9:10, pages 2152.
Crossref
Yanfeng HeShigeo SatoChieri Tomomori-SatoShiyuan ChenZach H. GoodeJoan W. Conaway & Ronald C. Conaway. (2021) Elongin functions as a loading factor for Mediator at ATF6α-regulated ER stress response genes. Proceedings of the National Academy of Sciences 118:39.
Crossref
Alice P. Rogers, Kathryn Friend, Lesley Rawlings & Christopher P. Barnett. (2021) A de novo missense variant in MED13 in a patient with global developmental delay, marked facial dysmorphism, macroglossia, short stature, and macrocephaly . American Journal of Medical Genetics Part A 185:8, pages 2586-2592.
Crossref
Tamiris Barros, Vinicius Venancio, Lívia Hernandes, Lusania Antunes, Elaine Hillesheim, Roberta Salomão, Mariana Mathias, Carolina Coelho-Landell, Roseli Toffano, Maria Almada, José Camelo-Junior, Sofia Moco, Ornella Cominetti, Fábio Ued, Jim Kaput & Jacqueline Monteiro. (2021) DNA Damage, n-3 Long-Chain PUFA Levels and Proteomic Profile in Brazilian Children and Adolescents. Nutrients 13:8, pages 2483.
Crossref
Haining Chen & B. Franklin Pugh. (2021) What do Transcription Factors Interact With?. Journal of Molecular Biology 433:14, pages 166883.
Crossref
Pratibha Srivastava, Ryosuke Takii, Mariko Okada, Mitsuaki Fujimoto & Akira Nakai. (2021) MED12 interacts with the heat‐shock transcription factor HSF1 and recruits CDK8 to promote the heat‐shock response in mammalian cells. FEBS Letters 595:14, pages 1933-1948.
Crossref
Emmanuel CompeJean-Marc Egly. (2021) The Long Road to Understanding RNAPII Transcription Initiation and Related Syndromes. Annual Review of Biochemistry 90:1, pages 193-219.
Crossref
Laia Richart, François-Clément Bidard & Raphaël Margueron. (2021) Enhancer rewiring in tumors: an opportunity for therapeutic intervention. Oncogene 40:20, pages 3475-3491.
Crossref
Srishti Srivastava & Ritu Kulshreshtha. (2020) Insights into the regulatory role and clinical relevance of mediator subunit, MED12, in human diseases. Journal of Cellular Physiology 236:5, pages 3163-3177.
Crossref
Dong Li, Alanna Strong, Kaitlyn M. Shen, David Cassiman, Maria Van Dyck, Natalia Duarte Linhares, Eugenia Ribeiro Valadares, Tiancheng Wang, Sergio D. J. Pena, Jaak Jaeken, Samantha Vergano, Elaine Zackai, Anne Hing, Penny Chow, Arupa Ganguly, Tasja Scholz, Tatjana Bierhals, Deindl Philipp, Hakon Hakonarson & Elizabeth Bhoj. (2020) De novo loss-of-function variants in X-linked MED12 are associated with Hardikar syndrome in females. Genetics in Medicine 23:4, pages 637-644.
Crossref
Dan Wu, Zhaoyan Zhang, Xing Chen, Yaoyao Yan & Xinhua Liu. (2021) Angel or Devil ? - CDK8 as the new drug target. European Journal of Medicinal Chemistry 213, pages 113043.
Crossref
Amanda C. Sharko, Chang-Uk Lim, Martina S. J. McDermott, Chuck Hennes, Kingsavanh P. Philavong, Tiffanie Aiken, Victor V. Tatarskiy, Igor B. Roninson & Eugenia V. Broude. (2021) The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs. Cells 10:1, pages 144.
Crossref
Kenly Wuputra, Chia-Chen Ku, Deng-Chyang Wu, Ying-Chu Lin, Shigeo Saito & Kazunari K. Yokoyama. (2020) Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Tizhi Wu, Zhen Qin, Yucheng Tian, Jubo Wang, Chenxi Xu, Zhiyu Li & Jinlei Bian. (2020) Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update. Journal of Medicinal Chemistry 63:22, pages 13228-13257.
Crossref
Emily M. Schleicher, Ashna Dhoonmoon, Lindsey M. Jackson, Kristen E. Clements, Coryn L. Stump, Claudia M. Nicolae & George-Lucian Moldovan. (2020) Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors. PLOS Genetics 16:11, pages e1009176.
Crossref
Pascal Loyer & Janeen H. Trembley. (2020) Roles of CDK/Cyclin complexes in transcription and pre-mRNA splicing: Cyclins L and CDK11 at the cross-roads of cell cycle and regulation of gene expression. Seminars in Cell & Developmental Biology 107, pages 36-45.
Crossref
Jianru Zhang, Xiaoyun Zhang, Huidan Huang & Yimei Ding. (2020) A review on kinases phosphorylating the carboxyl-terminal domain of RNA polymerase II—Biological functions and inhibitors. Bioorganic Chemistry 104, pages 104318.
Crossref
Wu Xu, Xiao-Jun Xie, Ali K. Faust, Mengmeng Liu, Xiao Li, Feng Chen, Ashlin A. Naquin, Avery C. Walton, Peter W. Kishbaugh & Jun-Yuan Ji. (2020) All-Atomic Molecular Dynamic Studies of Human and Drosophila CDK8: Insights into Their Kinase Domains, the LXXLL Motifs, and Drug Binding Site. International Journal of Molecular Sciences 21:20, pages 7511.
Crossref
Cian J. Lynch, Raquel Bernad, Ana Martínez-Val, Marta N. Shahbazi, Sandrina Nóbrega-Pereira, Isabel Calvo, Carmen Blanco-Aparicio, Carolina Tarantino, Elena Garreta, Laia Richart-Ginés, Noelia Alcazar, Osvaldo Graña-Castro, Gonzalo Gómez-Lopez, Irene Aksoy, Maribel Muñoz-Martín, Sonia Martinez, Sagrario Ortega, Susana Prieto, Elisabeth Simboeck, Alain Camasses, Camille Stephan-Otto Attolini, Agustin F. Fernandez, Marta I. Sierra, Mario F. Fraga, Joaquin Pastor, Daniel Fisher, Nuria Montserrat, Pierre Savatier, Javier Muñoz, Magdalena Zernicka-Goetz & Manuel Serrano. (2020) Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8/19 Mediator kinases. Nature Cell Biology 22:10, pages 1223-1238.
Crossref
Cian J. Lynch, Raquel Bernad, Isabel Calvo & Manuel Serrano. (2020) Manipulating the Mediator complex to induce naïve pluripotency. Experimental Cell Research 395:2, pages 112215.
Crossref
Xiao Lv, Yongbing Tian, Shiyu Li, Kai Cheng, Xufeng Huang, Haiyan Kong, Chenzhong Liao & Zhouling Xie. (2020) Discovery and Development of Cyclin-Dependent Kinase 8 Inhibitors. Current Medicinal Chemistry 27:32, pages 5429-5443.
Crossref
Emilie Lebraud, Guillaume Pinna, Capucine Siberchicot, Jordane Depagne, Didier Busso, Damiano Fantini, Lamya Irbah, Elena Robeska, Gueorgui Kratassiouk, Jean-Luc Ravanat, Bernd Epe, J Pablo Radicella & Anna Campalans. (2020) Chromatin recruitment of OGG1 requires cohesin and mediator and is essential for efficient 8-oxoG removal. Nucleic Acids Research 48:16, pages 9082-9097.
Crossref
Pabitra K. Parua & Robert P. Fisher. (2020) Dissecting the Pol II transcription cycle and derailing cancer with CDK inhibitors. Nature Chemical Biology 16:7, pages 716-724.
Crossref
Molly Butler, Nunya Chotiwan, Connie D. Brewster, James E. DiLisio, David F. Ackart, Brendan K. Podell, Randall J. Basaraba, Rushika Perera, Sandra L. Quackenbush & Joel Rovnak. (2020) Cyclin-Dependent Kinases 8 and 19 Regulate Host Cell Metabolism during Dengue Virus Serotype 2 Infection. Viruses 12:6, pages 654.
Crossref
Jordan L Kohlmeyer, David J Gordon, Munir R Tanas, Varun Monga, Rebecca D Dodd & Dawn E Quelle. (2020) CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets. International Journal of Molecular Sciences 21:8, pages 3018.
Crossref
Yi Kuang, Ohad Golan, Kristina Preusse, Brittany Cain, Collin J Christensen, Joseph Salomone, Ian Campbell, FearGod V Okwubido-Williams, Matthew R Hass, Zhenyu Yuan, Nathanel Eafergan, Kenneth H Moberg, Rhett A Kovall, Raphael Kopan, David Sprinzak & Brian Gebelein. (2020) Enhancer architecture sensitizes cell specific responses to Notch gene dose via a bind and discard mechanism. eLife 9.
Crossref
Allison C. Schier & Dylan J. Taatjes. (2020) Structure and mechanism of the RNA polymerase II transcription machinery. Genes & Development 34:7-8, pages 465-488.
Crossref
Sadie Rice, Seong-man Kim, Cynthia Rodriguez, William Songock, Gaurav Raikhy, Rebecca Lopez, Lauren Henderson, Arjun Yusufji & Jason Bodily. (2020) Suppression of a Subset of Interferon-Induced Genes by Human Papillomavirus Type 16 E7 via a Cyclin Dependent Kinase 8-Dependent Mechanism. Viruses 12:3, pages 311.
Crossref
Jonathan Chou, David A. Quigley, Troy M. Robinson, Felix Y. Feng & Alan Ashworth. (2020) Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy. Cancer Discovery 10:3, pages 351-370.
Crossref
Xueqin Xi, Yanfen Yao, Na Liu & Pibao Li. (2020) MiR-297 alleviates LPS-induced A549 cell and mice lung injury via targeting cyclin dependent kinase 8. International Immunopharmacology 80, pages 106197.
Crossref
Y. Y. Silaeva, V. A. Kalmykov, E. A. Varlamova, E. N. Korshunov, D. S. Korshunova, M. V. Kubekina, A. A. Shtil, I. B. Roninson & A. V. Deykin. (2020) Genome Editing As an Approach to the Study of in Vivo Transcription Reprogramming. Doklady Biochemistry and Biophysics 490:1, pages 43-46.
Crossref
Mengqian Chen, Jing Li, Jiaxin Liang, Zanshé S. Thompson, Katie Kathrein, Eugenia V. Broude & Igor B. Roninson. (2019) Systemic Toxicity Reported for CDK8/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition. Cells 8:11, pages 1413.
Crossref
Yuting Deng, Katherine Leisan Luo, Daniel D Shaye & Iva Greenwald. (2019) A Screen of the Conserved Kinome for Negative Regulators of LIN-12 Negative Regulatory Region (“NRR”)-Missense Activity in Caenorhabditis elegans . G3 Genes|Genomes|Genetics 9:11, pages 3567-3574.
Crossref
Li, Ji, Porter, Broude, Roninson & Chen. (2019) Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based Assay. Cells 8:10, pages 1208.
Crossref
Igor B. Roninson, Balázs Győrffy, Zachary T. Mack, Alexander A. Shtil, Michael S. Shtutman, Mengqian Chen & Eugenia V. Broude. (2019) Identifying Cancers Impacted by CDK8/19. Cells 8:8, pages 821.
Crossref
Yun Dai, Fengyan Jin, Wei Wu & Shaji K. Kumar. (2019) Cell cycle regulation and hematologic malignancies. Blood Science 1:1, pages 34-43.
Crossref
Xiao Li, Mengmeng Liu & Jun-Yuan Ji. 2019. The Drosophila Model in Cancer. The Drosophila Model in Cancer 129 155 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.